Canada markets close in 53 minutes
  • S&P/TSX

    20,404.42
    -57.51 (-0.28%)
     
  • S&P 500

    4,451.37
    +2.39 (+0.05%)
     
  • DOW

    34,777.86
    +13.04 (+0.04%)
     
  • CAD/USD

    0.7898
    -0.0005 (-0.06%)
     
  • CRUDE OIL

    73.94
    +0.64 (+0.87%)
     
  • BTC-CAD

    53,543.78
    -3,427.08 (-6.02%)
     
  • CMC Crypto 200

    1,053.07
    -49.99 (-4.53%)
     
  • GOLD FUTURES

    1,747.30
    -2.50 (-0.14%)
     
  • RUSSELL 2000

    2,253.49
    -5.55 (-0.25%)
     
  • 10-Yr Bond

    1.4580
    +0.0480 (+3.40%)
     
  • NASDAQ

    15,023.86
    -28.39 (-0.19%)
     
  • VOLATILITY

    17.86
    -0.77 (-4.13%)
     
  • FTSE

    7,051.48
    -26.87 (-0.38%)
     
  • NIKKEI 225

    30,248.81
    +609.41 (+2.06%)
     
  • CAD/EUR

    0.6739
    +0.0012 (+0.18%)
     

Global Fatigue Clinical Trials Review, H2 2021 - ResearchAndMarkets.com

·3 min read

DUBLIN, July 29, 2021--(BUSINESS WIRE)--The "Fatigue - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.

"Fatigue - Global Clinical Trials Review, H2, 2021" provides an overview of the Fatigue Clinical trials scenario. This report provides top line data relating to the clinical trials on Fatigue.

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months

Key Topics Covered:

  • Report Guidance

  • The Publisher's Clinical Trials Report Coverage

  • Clinical Trials by Region

  • Clinical Trials and Average Enrollment by Country

  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific

  • Top Five Countries Contributing to Clinical Trials in Europe

  • Top Countries Contributing to Clinical Trials in North America

  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa

  • Top Countries Contributing to Clinical Trials in Central and South America

  • Clinical Trials by G7 Countries: Proportion of Fatigue to Central Nervous System Clinical Trials

  • Clinical Trials by Phase in G7 Countries

  • Clinical Trials in G7 Countries by Trial Status

  • Clinical Trials by E7 Countries: Proportion of Fatigue to Central Nervous System Clinical Trials

  • Clinical Trials by Phase in E7 Countries

  • Clinical Trials in E7 Countries by Trial Status

  • Clinical Trials by Phase

  • In Progress Trials by Phase

  • Clinical Trials by Trial Status

  • Clinical Trials by End Point Status

  • Subjects Recruited Over a Period of Time

  • Clinical Trials by Sponsor Type

  • Prominent Sponsors

  • Top Companies Participating in Fatigue Therapeutics Clinical Trials

  • Prominent Drugs

  • Clinical Trial Profile Snapshots

  • Appendix

Companies Mentioned

  • Helsinn Group

  • Teva Pharmaceutical Industries Ltd

  • Maywufa Company Ltd

  • Ache Laboratorios Farmaceuticos SA

  • C. H. Boehringer Sohn AG & Co KG

  • Daewoong Co Ltd

  • Pfizer Inc

  • Tsumura & Co

  • Biogen Inc

  • Dr. Willmar Schwabe GmbH & Co KG

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/ksnks3

View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005684/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting